These 5 Drugmakers' Earnings Excelled This Quarter
at Investor's Business Daily - Tue Nov 04, 7:14PM CST
Big pharma firms such as Alexion Pharmaceuticals and Biogen Idec continue to outperform the market as they develop and market new treatments to treat long-time targets such as Alzheimer's as well as rare illnesses. Today's Screen Of The Day is Big...
AGN: 195.12 (+1.98), BIIB: 322.06 (+0.81), VRX: 133.61 (+0.76), ACT: 245.32 (-2.18), JAZZ: 168.48 (-1.85), ALXN: 191.30 (+0.26), CELG: 105.75 (-1.66)
Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 45.48 (-2.08), MNST: 100.04 (-1.19), SWKS: 60.42 (+0.19), GMCR: 152.11 (+0.21), ILMN: 191.41 (-2.92), WSM: 64.33 (-0.63), NXPI: 69.67 (+0.42), CELG: 105.75 (-1.66), HAIN: 106.79 (-1.55), AGN: 195.12 (+1.98), CNC: 92.04 (+0.47), V: 242.97 (+1.43), CALM: 43.15 (-0.17), JAZZ: 168.48 (-1.85), ALXN: 191.30 (+0.26), LOW: 57.26 (-0.19), ULTA: 120.11 (+0.20), MA: 83.99 (-0.14), AVGO: 85.36 (-0.98), PETM: 70.70 (-1.00)
Final Glance: Biotechnology companies
AP - Tue Nov 04, 5:02PM CST
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)
Next Support Level for Celgene (CELG) is $105.49
Comtex SmarTrend(R) - Tue Nov 04, 12:59PM CST
Shares of Celgene (NASDAQ:CELG) have bearishly opened below the pivot of $107.01 today and have reached the first support level of $106.45. Should the shares continue to fall, the support pivots of $105.49 and $103.97 will be of interest.
CELG: 105.75 (-1.66)
Midday Glance: Biotechnology companies
AP - Tue Nov 04, 12:22PM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)
Early Glance: Biotechnology companies
AP - Tue Nov 04, 9:49AM CST
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.:
GILD: 109.72 (-0.26), AMGN: 160.41 (-1.15), CELG: 105.75 (-1.66)
'Mad Money' Lightning Round: I'm Not Crazy About Sysco Anymore
at The Street - Tue Nov 04, 5:00AM CST
Cramer thinks Celgene is a monster stock, says Aramark is a great company and prefers Kinder Morgan over Linn Energy.
KMI: 37.46 (-1.04), ARMK: 28.23 (+0.27), SYY: 37.36 (-0.13), OHI: 38.18 (-0.07), LINE: 23.11 (-1.79), VTR: 69.13 (+0.38), CSCO: 24.88 (+0.30), FEIC: 84.20 (+0.61), EGHT: 7.71 (-0.02), CELG: 105.75 (-1.66)
Jim Cramer's 'Mad Money' Recap: Merger Monday Has Returned
at The Street - Mon Nov 03, 7:14PM CST
LabCorp buying Covance is a win-win for investors, Cramer says.
HYH: 36.97 (-1.48), KMI: 37.46 (-1.04), FB: 75.76 (+1.88), KMB: 113.16 (+1.80), SYY: 37.36 (-0.13), GOOG: 554.11 (-1.11), WM: 48.34 (-0.27), VTR: 69.13 (+0.38), CELG: 105.75 (-1.66), CVD: 100.80 (+0.23), FEIC: 84.20 (+0.61), ARMK: 28.23 (+0.27), SAPE: 24.66 (+0.06), OHI: 38.18 (-0.07), LH: 102.38 (+1.15), LINE: 23.11 (-1.79), TWTR: 40.90 (+0.69), CSCO: 24.88 (+0.30), BABA: 106.07 (+4.27), EGHT: 7.71 (-0.02)
Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 238.43 (+5.35), ALXN: 191.30 (+0.26), ILMN: 191.41 (-2.92), REGN: 372.39 (-22.87), CRM: 63.57 (-0.02), CELG: 105.75 (-1.66)
Cramer Sees HP Entering Sector as Trouble for 3-D Printing Stocks
at The Street - Mon Nov 03, 10:57AM CST
Even though HP won't start shipping its 3-D printing machines in bulk until 2016, it could be a problem for other 3-D printing companies.
BMRN: 83.46 (-1.12), ISIS: 45.60 (-0.33), SGEN: 36.57 (-0.68), GILD: 109.72 (-0.26), SSYS: 121.25 (-1.32), HP: 80.69 (-3.60), REGN: 372.39 (-22.87), CELG: 105.75 (-1.66)
'Fast Money' Recap: Will Japan's Stimulus Lead to U.S. Deflation?
at The Street - Sat Nov 01, 4:00AM CDT
The trading panel discussed the S&P 500, whether to buy Apple and if Kim Kardasian is the only thing Glu Mobile has going for it.
FDX: 166.96 (-0.24), HD: 95.96 (-0.13), C: 53.19 (-0.28), SNE: 20.01 (-0.15), BBY: 34.36 (-0.05), GLUU: 3.81 (-0.18), CELG: 105.75 (-1.66), DXJ: 53.51 (-1.52), SBUX: 76.71 (+0.61), GS: 190.27 (-0.56), EXPE: 83.89 (-2.04), AAPL: 108.60 (-0.80), CTRL: 14.93 (-0.66)
IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 74.65 (+1.07), AAP: 148.44 (+0.68), AKRX: 42.64 (-1.18), ILMN: 191.41 (-2.92), NXPI: 69.67 (+0.42), CDW: 31.04 (-0.02), CELG: 105.75 (-1.66), BIDU: 241.96 (+5.42), GILD: 109.72 (-0.26), JAZZ: 168.48 (-1.85), FLT: 148.53 (-1.70), FL: 53.63 (-2.54), AAPL: 108.60 (-0.80), AVGO: 85.36 (-0.98)
Celgene Corporation to Webcast at Upcoming Investor Conferences and Medical Congress
Business Wire - Fri Oct 31, 7:30AM CDT
Celgene Corporation (NASDAQ:CELG) plans to present at two upcoming investor conferences, where Celgene management will provide an overview of the Company, and at the 56th American Society of Hematology (ASH) annual meeting in December. The conferences and ASH event will be webcast live and the webcast will be available in the Investor Relations section of the Company's website at www.celgene.com.
CELG: 105.75 (-1.66), CELGZ: 3.62 (+0.02)
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
at The Street - Fri Oct 31, 5:00AM CDT
Cramer says Take-Two Interactive is king of the hill and he's a big fan of Flextronics and its stock buyback program.
FLEX: 10.79 (+0.01), TTWO: 25.92 (+0.09), BIIB: 322.06 (+0.81), GILD: 109.72 (-0.26), CRL: 64.12 (-0.31), REGN: 372.39 (-22.87), CELG: 105.75 (-1.66)
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong
at The Street - Thu Oct 30, 7:11PM CDT
The end of quantitative easing was supposed to create a laundry list of problems, Cramer says. It didn't happen.
MMM: 155.05 (+1.75), BIIB: 322.06 (+0.81), HON: 95.29 (-0.37), FB: 75.76 (+1.88), BMY: 57.84 (+0.04), MGM: 22.33 (-0.69), ATK: 112.87 (-4.20), YRCW: 22.90 (+0.61), UPS: 107.08 (+1.44), SLB: 94.16 (-2.36), CELG: 105.75 (-1.66), WPRT: 5.82 (-0.15), SBUX: 76.71 (+0.61), TTWO: 25.92 (+0.09), DO: 33.50 (-1.22), ETP: 63.24 (-1.16), GILD: 109.72 (-0.26), ARR: 3.93 (-0.03), CMG: 647.68 (+9.15), MPEL: 25.47 (-1.10), WNC: 10.30 (+0.16), CRL: 64.12 (-0.31), AAPL: 108.60 (-0.80), REGN: 372.39 (-22.87)